Oculis Holding AG (OCS) Invested Capital (2021 - 2025)
Oculis Holding AG (OCS) recorded quarterly Invested Capital of $73.4 billion in Q4 2025, up 44.03% quarter-over-quarter from $51.0 billion in Q4 2024, and up 44.03% on a YoY basis from $51.0 billion in Q4 2024.
Oculis Holding AG (OCS) Invested Capital (2021 - 2025) Analysis & Trends
Oculis Holding AG's Invested Capital history runs 5 years deep, the most recent figure standing at $73.4 billion for Q4 2025.
- In Q4 2025, Invested Capital rose 44.03% year-over-year to $73.4 billion; the TTM figure through Dec 2025 stood at $73.4 billion (up 44.03% YoY), while the FY2025 annual figure was $73.4 billion, up 44.03% from the prior year.
- Invested Capital was $73.4 billion for Q4 2025 at Oculis Holding AG, up from $51.0 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $73.4 billion in Q4 2025 to a low of -$101.7 million in Q4 2022.
- Historically, Invested Capital has averaged $33.1 billion across 5 years, with a median of $41.3 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Invested Capital sank 53.87% in 2022, then surged 40719.85% in 2023.
- A 5-year view of Invested Capital shows it stood at -$66.1 million in 2021, then sank by 53.87% to -$101.7 million in 2022, then soared by 40719.85% to $41.3 billion in 2023, then advanced by 23.39% to $51.0 billion in 2024, then surged by 44.03% to $73.4 billion in 2025.
- The last three Invested Capital figures came in at $73.4 billion (Q4 2025), $51.0 billion (Q4 2024), and $41.3 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 502.95 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.43 Bn |
| Dec 31, 2024 | 50.98 Bn |
| Dec 31, 2023 | 41.32 Bn |
| Dec 31, 2022 | -101.72 Mn |
| Dec 31, 2021 | -66.11 Mn |